Literature DB >> 32272000

Barriers to blood pressure control in China in a large opportunistic screening.

Xin Chen1, Shao-Kun Xu2, Qian-Hui Guo2, Zhe Hu1, Hong-Yu Wang3, Jing Yu4, Wei-Hua Li5, Guo-Bao Tang5, Hai-Feng Zhang6, Yan Li2, Ji-Guang Wang1,2.   

Abstract

We investigated the prevalence, awareness, treatment, and control of hypertension in a large opportunistic screening study in China. Our study participants had to be ≥18 years of age and had ideally not taken blood pressure (BP) for ≥1 year. BP was measured three times consecutively in the sitting position with a 1-minute interval, using a validated electronic BP monitor or mercury sphygmomanometer. Trained volunteer investigators administered a questionnaire to collect information on medical history, lifestyle, and use of medications. The 364 000 participants (52.6% women, and mean age 53.4 years) had a mean systolic/diastolic BP of 124.2/76.4 mm Hg. The proportion of hypertension was 24.7%. In all hypertensive subjects (n = 89 925), the awareness, treatment, and control rates of hypertension were 60.1%, 42.5%, and 25.4%, respectively. In multiple stepwise logistic regression analyses, the odds for unawareness vs awareness of hypertension was higher in men and lower with age advancing, current smoking, and the presence of diabetes mellitus, coronary heart disease, and stroke or transient ischemic attack (P < .0001). The odds for uncontrolled vs controlled hypertension was higher with age advancing and current smoking, and lower with the presence of diabetes mellitus and coronary heart disease (P ≤ .03) in 38 207 treated hypertensive patients, and it was also higher with the use of antihypertensive monotherapy (odds ratio 1.13, P = .0003) in 19 523 treated hypertensive patients with specific antihypertensive drugs. Our study identified several factors as barriers to BP control in China, such as male gender, younger age, current smoking, and the under-use of combination therapy.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  China; awareness; blood pressure; control; hypertension; treatment

Mesh:

Substances:

Year:  2020        PMID: 32272000      PMCID: PMC8029917          DOI: 10.1111/jch.13850

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  23 in total

Review 1.  Unique approaches to hypertension control in China.

Authors:  Ji-Guang Wang
Journal:  Ann Transl Med       Date:  2018-08

2.  2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension.

Authors: 
Journal:  J Geriatr Cardiol       Date:  2019-03       Impact factor: 3.327

3.  2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  J Hypertens       Date:  2018-10       Impact factor: 4.844

Review 4.  A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.

Authors:  Michael H Olsen; Sonia Y Angell; Samira Asma; Pierre Boutouyrie; Dylan Burger; Julio A Chirinos; Albertino Damasceno; Christian Delles; Anne-Paule Gimenez-Roqueplo; Dagmara Hering; Patricio López-Jaramillo; Fernando Martinez; Vlado Perkovic; Ernst R Rietzschel; Giuseppe Schillaci; Aletta E Schutte; Angelo Scuteri; James E Sharman; Kristian Wachtell; Ji Guang Wang
Journal:  Lancet       Date:  2016-09-23       Impact factor: 79.321

5.  Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014.

Authors:  Yiyi Zhang; Andrew E Moran
Journal:  Hypertension       Date:  2017-08-28       Impact factor: 10.190

6.  Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.

Authors:  Zengwu Wang; Zuo Chen; Linfeng Zhang; Xin Wang; Guang Hao; Zugui Zhang; Lan Shao; Ye Tian; Ying Dong; Congyi Zheng; Jiali Wang; Manlu Zhu; William S Weintraub; Runlin Gao
Journal:  Circulation       Date:  2018-02-15       Impact factor: 29.690

7.  Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013.

Authors:  Minghuan Wang; Xiang Luo; Shabei Xu; Wenhua Liu; Fengfei Ding; Xiaoxiang Zhang; Liang Wang; Jian Liu; Jianping Hu; Wei Wang
Journal:  Lancet Respir Med       Date:  2018-10-25       Impact factor: 30.700

8.  The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China.

Authors:  Sarah Lewington; Ben Lacey; Robert Clarke; Yu Guo; Xiang Ling Kong; Ling Yang; Yiping Chen; Zheng Bian; Junshi Chen; Jinhuai Meng; Youping Xiong; Tianyou He; Zengchang Pang; Shuo Zhang; Rory Collins; Richard Peto; Liming Li; Zhengming Chen
Journal:  JAMA Intern Med       Date:  2016-04       Impact factor: 21.873

9.  Prevalence, awareness, treatment and control of hypertension in elderly Chinese.

Authors:  Chang-Sheng Sheng; Ming Liu; Yuan-Yuan Kang; Fang-Fei Wei; Lu Zhang; Ge-Le Li; Qian Dong; Qi-Fang Huang; Yan Li; Ji-Guang Wang
Journal:  Hypertens Res       Date:  2013-06-13       Impact factor: 3.872

Review 10.  Hypertension and Related Cardiovascular Disease Burden in China.

Authors:  Joshua D Bundy; Jiang He
Journal:  Ann Glob Health       Date:  2016 Mar-Apr       Impact factor: 2.462

View more
  4 in total

1.  Barriers to blood pressure control in China in a large opportunistic screening.

Authors:  Xin Chen; Shao-Kun Xu; Qian-Hui Guo; Zhe Hu; Hong-Yu Wang; Jing Yu; Wei-Hua Li; Guo-Bao Tang; Hai-Feng Zhang; Yan Li; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

Review 2.  Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring.

Authors:  Ji-Guang Wang; Yan Li; Yook-Chin Chia; Hao-Min Cheng; Huynh Van Minh; Saulat Siddique; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Yuda Turana; Tzung-Dau Wang; Yu-Qing Zhang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-23       Impact factor: 3.738

3.  May Measurement Month 2019: an analysis of blood pressure screening results from China.

Authors:  Xin Chen; Chang-Yuan Liu; Li-Ying Xu; Hong-Yu Wang; Min Liu; Yu-Qing Zhang; Xin-Hua Yin; Xiao-Long Wang; Jing Yu; Wei-Hua Li; Thomas Beaney; Xin Xia; Neil R Poulter; Yan Li; Ji-Guang Wang
Journal:  Eur Heart J Suppl       Date:  2021-05-20       Impact factor: 1.803

4.  Risk Prediction Model for Uncontrolled Hypertension in Chinese Community.

Authors:  Zhiping Gao; Shiqun Chen; Xiaoyu Huang; Jianfeng Ye; Jin Liu; Zhidong Huang; Jiyan Chen; Liwen Li; Yong Liu; Shuguang Lin
Journal:  Front Cardiovasc Med       Date:  2022-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.